OHI Q1 2026 Earnings Strong EPS Surprise Amidst Flat Revenue Disclosure and Slight Stock Decline TXMD Q3 2023 Earnings A Significant EPS Miss Amid No Reported Revenue IO Biotech Q3 2025 Earnings EPS Beat of 6067 Surprise but No Revenue from PreCommercial Pipeline Core Laboratories Q1 2026 Earnings EPS Misses Estimates as Market Challenges Persist RYZ Q1 2026 Earnings EPS Misses Estimates Stock Gains on Recovery Hopes HWBK Q1 2026 Earnings Solid EPS Performance Amidst Cautious Market Reception